• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SOHO 最新进展及后续问题:晚期 CTCL 系统性治疗的现代方法。

SOHO State-of-the-Art Updates and Next Questions: A Modern Approach to the Systemic Treatment of Advanced CTCL.

机构信息

Department of Medicine, University of California Irvine Medical Center, Orange, CA.

Department of Medicine, University of California Irvine Medical Center, Orange, CA; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA.

出版信息

Clin Lymphoma Myeloma Leuk. 2023 Jun;23(6):401-409. doi: 10.1016/j.clml.2023.03.003. Epub 2023 Mar 17.

DOI:10.1016/j.clml.2023.03.003
PMID:37061415
Abstract

The term cutaneous T-cell lymphoma (CTCL) is a general term for T-cell lymphomas that are found primarily in skin. The most common CTCL entities, mycosis fungoides and Sezary syndrome are incurable diseases with a plethora of conventional treatment options. In the past treatment options have been selected primarily according to stage. Given newer targeted therapies with varied response in different body compartments, we suggest a compartment-guided algorithm that may enhance response rates directing the selection of the most efficacious treatment options.

摘要

皮肤 T 细胞淋巴瘤(CTCL)是一个广义术语,用于指代主要发生在皮肤的 T 细胞淋巴瘤。蕈样真菌病和 Sezary 综合征是最常见的 CTCL 实体,它们是无法治愈的疾病,有大量的常规治疗选择。过去,治疗选择主要根据分期进行。鉴于不同身体部位对不同靶向治疗的反应不同,我们建议采用基于部位的算法,这可能会提高反应率,指导选择最有效的治疗方法。

相似文献

1
SOHO State-of-the-Art Updates and Next Questions: A Modern Approach to the Systemic Treatment of Advanced CTCL.SOHO 最新进展及后续问题:晚期 CTCL 系统性治疗的现代方法。
Clin Lymphoma Myeloma Leuk. 2023 Jun;23(6):401-409. doi: 10.1016/j.clml.2023.03.003. Epub 2023 Mar 17.
2
Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update.治疗皮肤 T 细胞淋巴瘤(CTCL)的研究性药物:最新进展。
Expert Opin Investig Drugs. 2019 Sep;28(9):799-809. doi: 10.1080/13543784.2019.1654995. Epub 2019 Aug 18.
3
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.原发性皮肤 T 细胞淋巴瘤(蕈样肉芽肿和赛泽里综合征):第一部分。诊断:临床和组织病理学特征以及新的分子和生物学标志物。
J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049.
4
Spotlight on Mogamulizumab-Kpkc for Use in Adults with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome: Efficacy, Safety, and Patient Selection.聚焦莫格利珠单抗 - Kpkc 在成人复发或难治性蕈样真菌病或塞扎里综合征中的应用:疗效、安全性和患者选择。
Drug Des Devel Ther. 2020 Sep 16;14:3747-3754. doi: 10.2147/DDDT.S185896. eCollection 2020.
5
[Rare variants of cutaneous T-cell lymphomas].[皮肤T细胞淋巴瘤的罕见变体]
Hautarzt. 1996 Feb;47(2):96-105. doi: 10.1007/s001050050384.
6
Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas.侵袭性皮肤 T 细胞淋巴瘤患者的生存和预后因素。
Acta Derm Venereol. 2022 Mar 22;102:adv00676. doi: 10.2340/actadv.v102.1087.
7
Romidepsin for the treatment of relapsed/refractory cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome): Use in a community setting.罗米地辛治疗复发/难治性皮肤 T 细胞淋巴瘤(蕈样真菌病/赛泽里综合征):在社区环境中的应用。
Crit Rev Oncol Hematol. 2016 Oct;106:99-107. doi: 10.1016/j.critrevonc.2016.07.001. Epub 2016 Jul 5.
8
Cutaneous T-cell lymphoma. Refinement in the application of controversial histologic criteria.皮肤T细胞淋巴瘤。争议性组织学标准应用的细化。
Dermatol Clin. 1999 Jul;17(3):601-14, ix. doi: 10.1016/s0733-8635(05)70110-8.
9
Current status of histone deacetylase inhibitors in cutaneous T-cell lymphoma.组蛋白去乙酰化酶抑制剂在皮肤 T 细胞淋巴瘤中的现状。
G Ital Dermatol Venereol. 2019 Dec;154(6):681-695. doi: 10.23736/S0392-0488.19.06503-9.
10
Tumor microenvironment in mycosis fungoides and Sézary syndrome.蕈样肉芽肿和塞扎里综合征中的肿瘤微环境。
Curr Opin Oncol. 2016 Jan;28(1):88-96. doi: 10.1097/CCO.0000000000000243.

引用本文的文献

1
Non-coding RNAs in the spotlight of the pathogenesis, diagnosis, and therapy of cutaneous T cell lymphoma.非编码RNA在皮肤T细胞淋巴瘤发病机制、诊断及治疗中的研究热点
Cell Death Discov. 2024 Sep 10;10(1):400. doi: 10.1038/s41420-024-02165-2.
2
Assessing the Efficacy of Bortezomib and Dexamethasone for Induction and Maintenance Therapy in Relapsed/Refractory Cutaneous T-Cell Lymphoma: A Phase II CISL1701/BIC Study.评估硼替佐米与地塞米松用于复发/难治性皮肤T细胞淋巴瘤诱导和维持治疗的疗效:一项II期CISL1701/BIC研究
Cancer Res Treat. 2025 Jan;57(1):267-279. doi: 10.4143/crt.2024.479. Epub 2024 Jul 16.
3
Broadening the horizon: potential applications of CAR-T cells beyond current indications.
拓宽视野:CAR-T 细胞在现有适应证之外的潜在应用。
Front Immunol. 2023 Nov 27;14:1285406. doi: 10.3389/fimmu.2023.1285406. eCollection 2023.